S2 Ep33: PER Podcast™: Maximizing the Multidisciplinary Care Outcomes of Patients with Amyotrophic Lateral Sclerosis (ALS)

PER Podcast Sessions

Content provided by PER Spectives and PER® Spectives. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by PER Spectives and PER® Spectives or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

2M ago 24:46

MP3•Episode home

Episode Description

In this podcast, ALS expert clinician-researcher Richard Bedlack MD, PhD, discusses targeted therapy for ALS and the role of individualized, multidisciplinary care to optimize patient outcomes.
Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

Discuss the mechanisms of action, efficacy, and safety of approved and emerging treatments for patients with ALS
Develop individualized, multidisciplinary ALS management plans in collaboration with the patient and caregiver

Acknowledgment of Educational Grant Support

This activity is supported by an educational grant from Mitsubishi Tanabe Pharma America.
Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 0.5 Contact Hours.
Instructions on How to Receive Credit

Listen to this podcast in its entirety.
Go to gotoper.com/credit and enter code: 3543
Answer the evaluation questions.
Request credit using the drop-down menu.

You may immediately download your certificate.
Chair:
Richard Bedlack, MD, PhD

Stewart, Hughes, and Wendt Distinguished Professor
Director of ALS Program
Duke University Department of Neurology
Durham, NC
Disclosures: Consultant: AB Science, Advarra, ALS Association, Amylyx, Biogen Idec, Capvision, CareSpace Health, ClearView, Compassionate Care ALS, Eikonoklastes, Guidepoint Global, Health Advances, Health Care Strategy Partners, Ionis Pharmaceuticals, Kaplan, KeyQuest, Med-IQ, NeuroSense, Novartis, Prime Education, PTC Therapeutics, Roon; Research Support: Healey Center, MediciNova; Advisory Board: GenieUs; Other: Biogen, Ionis, NeuroSense, PTC.

Faculty, Staff, and Planners’ Disclosures
In accordance with ACCME Guidelines, PER® has identified and resolved all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
This podcast was developed by PER® editorial staff based on an online activity developed with these faculty.

Release Date

June 23, 2025
Expiration Date

June 23, 2026
Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

60 episodes

#Science #Biology #Podcasting Education #Medicine #Spectives